Dr. Joanna Moncrieff: O Desafio da Nova Onda dos Antidepressivos

0

This week we interview Dr. Joanna Moncrieff. Dr. Moncrieff is a psychiatrist, academic and author. She has an interest in the history, philosophy and politics of psychiatry, and particularly in the use, misuse and misrepresentation of psychiatric drugs. As an author, Dr. Moncrieff has written extensively on psychiatric drugs and her books include The Myth of the Chemical Cure, A Straight Talking Introduction to Psychiatric Drugs and The Bitterest Pills: the troubling story of antipsychotic drugs.

She is one of the founding members of the Critical Psychiatry Network which consists of psychiatrists from around the world who are sceptical of the idea that mental disorders are simply brain diseases and of the dominance of the pharmaceutical industry.

We talk about the recent meta-analysis of the efficacy and tolerability of 21 antidepressant drugs, widely reported in the UK news media on February 22nd.

In the episode we discuss:

  • The approach taken in the largest ever meta-analysis of efficacy and tolerability of 21 common antidepressant drugs.
  • The problems inherent in comparing antidepressants with each other, as opposed to trials that compare the active drug to a placebo.
  • That the main conclusion reached was that all the antidepressants studied were better than placebo at reducing depressive symptoms.
  • The limitations of the study, particularly how response rate was selected as the primary outcome measure.
  • That ‘response’  is mostly defined as a reduction in the Hamilton Depression Rating Scale (or other scale) rating of 50% or more during the study.
  • That the response rate can artificially inflate the difference between drug and placebo.
  • The problems with blinding in the supporting trials and the effects of including people who are already receiving antidepressant treatment.
  • That the study did not include adverse effects or withdrawal difficulties, only dropout rates which are not representative of the whole picture of taking the drugs.
  • The short-term nature of the supporting trials, mainly 8 weeks, with a range of 4 to 12 weeks, which cannot be easily compared with the real world experience of people taking the drugs for much longer periods.
  • That, when the primary data is analysed (the depression rating scale scores) the differences between placebo and antidepressants are very small and probably clinically insignificant.
  • The uncritical and sensational nature of the media reporting of the study and the link to the Science Media Centre.
  • The concerns about the reporting that depression is under-treated in the UK which is not supported by the results of the study.
  • That people should carefully consider the balance of benefit versus risk, taking into account the potential for adverse effects or difficulties stopping the drugs.

Relevant links:

Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis

Challenging the New Hype About Antidepressants

The Hamilton Depression Scale

Empirically derived criteria cast doubt on the clinical significance of antidepressant-placebo differences

Efficacy of antidepressants in adults

The Science Media Centre

To get in touch with us email: [email protected]

Jim van Os: Repensando a Psiquiatria Biológica

0

This week on the Mad in America podcast we interview Professor Jim van Os.

Professor van Os is Chairman of the Department of Psychiatry and Psychology at Maastricht University Medical Centre, Maastricht, The Netherlands, and Visiting Professor of Psychiatric Epidemiology at King’s College, Institute of Psychiatry, London.

He trained in Psychiatry in Casablanca, Bordeaux and the Institute of Psychiatry and the Maudsley Royal Hospital in London.

In 2011, he was elected member of the Royal Netherlands Academy of Arts and Sciences (KNAW); he appears on the 2014 Thomson-Reuter Web of Science list of the world’s most influential scientific minds of our time.

He is Director of Psychiatric Services at Maastricht University Medical Centre and runs a service for treatment-resistant depression and first episode psychosis.

I was keen to ask Professor van Os about his views on biological psychiatry, why we should sometimes challenge schizophrenia, psychosis and other diagnostic terminology, and how he sees the future of mental healthcare.

In this episode we discuss:

  • How Jim became interested in Psychology and Psychiatry, partly because of the experiences of family members
  • That Jim felt that training in many parts of the world allowed him to see variations in psychiatric models and this led to him questioning the biological model
  • That Jim also saw how dominant the prescribing of medication but noticed the wide variation in practices
  • How Jim observed in France a willingness by the treating doctors to accept that they didn’t know what the root cause of a mental health difficulty
  • That some of the diagnoses that psychiatrists rely on are actually cultural agreements between professionals and that if a patient accepts the idea that they have a diseased brain, it can be limiting for that patient
  • That we should be able to admit that we don’t know causes but we can still help and support people who struggle with their mental health
  • That there is a 25% yearly prevalence of mental disorders, but many nations have a capacity for only 4% to 6% of the general population
  • That selection criteria to get help and support with their mental health just don’t work because we cannot precept outcomes for people
  • That there are interesting developments in eCommunities where people can participate in online communities to share experiences, for example ‘Proud to be Me’ in the Netherlands.
  • That diagnoses are starting to function as an economic measurement of mental illness and treatment and some cannot access treatment without a diagnosis, which perpetuate the diagnostic paradigm
  • That there were attempts in the most recent Diagnostic and Statistical Manual (DSM V) discussions to adopt ranges or dimensions of disorders, but the proposal was shot down
  • That it would have been historic if dimensions were adopted in the DSM because then the discussion between the clinician and the patient would have had to change
  • That there is some dimensionality in DSM V, represented as ‘spectrum disorders’ which are the first step towards acknowledging the variations inherent in human experiences
  • That Jim saw in his own family that the initial ‘relief’ of receiving a diagnosis was undone when more and more diagnoses were added
  • That a label of Schizophrenia can mean that other people do not know what to expect and find it difficult to relate psychologically to that person and their experiences
  • That the Maastricht User Research Centre has been discussing the language used in psychiatry, in particular the terms psychosis and schizophrenia and trying to find more helpful terms, for example hyper-meaning
  • That sometimes terms such as ‘susceptibility’ and ‘syndrome’ are far more helpful than giving someone the message that they have a brain disease
  • That biological psychiatry has been trying to reverse engineer and validate the concept of schizophrenia by investigating case control differences
  • That there is more awareness developing about the critical appraisal of diagnostic terminology
  • That the mental health sector should not be viewed as a separate entity, but should reinvent itself as an inclusive local community that is there to connect with people and their range of experiences
  • That patients often indicate that what got them better was community and connection and meaning and empowerment
  • That the User Research Centre, led by Dr. Peter Groot, have developed a solution to help patients withdraw slowly and gradually from their psychiatric medications
  • That when prescribing medication, we should encourage people to monitor their experiences to allow a better discussion about treatment continuing or stopping based on evidence
  • That if we suppress difficulties with medication, it can make it more difficult for the person to build up coping mechanisms

Relevant Links:

Professor Jim van Os

Tedx: Maastricht, Connecting to Madness

Jim van Os interview on Mad in America

Schizophrenia does not exist

Tapering Strips

How to Listen:

To listen in iTunes, click here

To listen on YouTube, click here

To get in touch with us email: [email protected]

Johann Hari: Conexões Perdidas

0

This week we interview journalist and author Johann Hari. Johann is one of our foremost social science thinkers and writers. In addition to writing regularly for the New York Times and Independent newspapers, he has written extensively on social science and human rights issues. His 2015 book Chasing the Scream: The First and Last Days of the War on Drugs, challenges what we believe about addiction, and his TED talk on our response to addiction has been viewed over 20 million times.

Johann was twice named ‘National Newspaper Journalist of the Year’ by Amnesty International. And he has been named ‘Cultural Commentator of the Year’ and ‘Environmental Commentator of the Year’ at the Comment Awards.

In this interview, we talk about Johann’s latest book, Lost Connections: Uncovering the Real Causes of Depression and the Unexpected Solutions, which has been called a ‘game changer’ and received plaudits for its explanation of the social and cultural issues leading to depression and anxiety.

In the episode we discuss:

  • How Johann became interested in journalism and began writing about social justice and human rights issues.
  • What led to wanting to write a book that was partly based on his own experiences with depression and anxiety, but also that provided the evidence for social and cultural issues that may underlie the dramatic increase in the number of people seeking support for emotional distress.
  • The facts behind the chemical imbalance theory of mental illness.
  • The role of the bio-psycho-social model of mental distress and why we may have focussed predominantly on biological interventions.
  • Social prescribing as a means to enable connection between people who struggle with depression and anxiety.
  • The Hamilton Depression scale and how it shows us that the effect of antidepressant drugs is small when compared to the improvements that can be achieved without drug therapy.
  • How Johann would like to widen the definition of what may be considered an ‘antidepressant’.
  • How disempowerment often lies at the heart of poor health.
  • How stigma relates to our perceptions of an individual who is labelled mentally ill and how it changes if we think someone has a biological problem.
  • Johann’s experiences in the Berlin district of Kotti.
  • That people can hear audio of the many of the interviews held for the book at https://thelostconnections.com

Relevant links:

Lost Connections: Uncovering the Real causes of Depression and the Unexpected Solutions

Johann Hari talk at the Royal Society for the encouragement of Arts, Manufacturers and Commerce (RSA)

Chasing the Scream: The First and Last Days of the War on Drugs

TED Talk, Everything you think you know about addition is wrong

To get in touch with us email: [email protected]

Kermit Cole: Abordagens Dialógicas para Estados Extremos

0

This week, we interview Kermit Cole. 

Kermit’s first career was in film and television, directing, amongst others, Living Proof: HIV and the Pursuit of Happiness in 1994.

Kermit has undergraduate and master’s degrees in psychology from Harvard and he has over two decades experience working with people in extreme states. He likes to say that he likes to work with trauma, especially when it’s being called something else – such as “psychosis”. Together with his partner Louisa Putnam, he works with couples and families with members who have been labeled as having a mental illness, seeking other ways to understand their struggles – ways that often lead to better outcomes.

Kermit has been part of the team at Mad in America since it was founded in January 2012.

I was keen to ask Kermit about what led to his interest in therapeutic work, his experiences of supporting those in extreme states and his thoughts on Open Dialogue and dialogical approaches in general.

In this episode, we discuss:

  • How Kermit came to be involved with a photo project that aimed to change the dominant image usually portrayed for those with HIV or AIDS and how that led to his 1994 film: Living Proof: HIV and the Pursuit of Happiness
  • How Kermit came to feel that a persons life should not be appraised based on its duration
  • How he went on to make the transition from filmmaker to supporting others with their mental health and wellbeing
  • That Kermit came to feel that having a camera got in the way of the connection that he wanted to make with people
  • How he went back to study and developed an interest in trauma and its impact on people and came to develop the skills necessary to be comfortable dealing with extreme states
  • His experiences working on a helpline for people experiencing suicidal thoughts and in a group home setting
  • How it felt to support those in distress without judgement or control, but just being with them and how not being alone sometimes makes a big difference
  • How sometimes supporting someone means not judging but also not colluding with beliefs that may come across as delusional, and how this is different to the approach of trying to medicate away behaviour that has been classified as aberrant
  • That Kermit feels blessed that he could choose between schooling and study or the risk of depression, diagnosis and hospital, but that many are not so fortunate
  • How Kermit and Louisa work together to support people struggling with their mental health through a family therapeutic approach and based on Open Dialog principles
  • That it is important to respond to a network that is in crisis, such as the family unit, rather than a single individual
  • That this approach used in Tornio, Finland resulted in excellent outcomes for patients and a lowering of municipal expenditure on mental health crises
  • How Louisa and Kermit approach working together in an open dialog model
  • How, if you can find a way for people to safely do what they would naturally want to do, then it can be helpful
  • How Kermit became involved with Mad in America after reading Robert Whitaker’s books
  • That taking medication could almost be viewed as an act of communion
  • That life, being human, hurts, but by learning to connect we can ameliorate the trauma

Relevant Links:

Kermit Cole, family therapist

From film director to group home director

Living Proof: HIV and the Pursuit of Happiness

Kermit and Louisa on the Dr. Peter Breggin hour podcast

Soteria Network UK

Open Dialogue


How to Listen:

To listen in iTunes, click here

To listen on YouTube, click here

To get in touch with us email: [email protected]

Olga Runciman: Moving Beyond Psychiatry

0

This week we interview Olga RuncimanOlga is an international trainer and speaker, writer, campaigner, and artist. She co-founded the Danish Hearing Voices Network and sees the role of the Hearing Voices Movement as post-psychiatric, working towards the recognition of human rights while offering hope, empowerment, and access to making sense of individual experiences.

Olga was a psychiatric nurse working in social psychiatry but today she is a psychologist and since 2013 she has had her own private practice in Denmark, working with people who have been labelled schizophrenic or psychotic. Olga is herself a psychiatric survivor and a voice hearer too.

In this interview, we discuss Olga’s professional and personal experiences of the psychiatric system and how she now helps and supports healing and recovery in others.

In the episode we discuss:

  • How Olga became a specialist psychiatric nurse in Denmark, believing at the time the reasons given for psychiatric diagnoses.
  • How she came to see that there was little evidence or corroboration to underpin the diagnosis and treatment that she witnessed.
  • How Olga was also a voice hearer but kept this hidden from her psychiatric colleagues.
  • How, when experiencing stress and trauma, Olga came to be admitted to a psychiatric ward, diagnosed as schizophrenic and treated with a cocktail of psychiatric drugs.
  • Olga’s experiences of the antipsychotic drug Clozapine.
  • How Olga came to stop her psychiatric drugs which she had been taking for ten years.
  • Psychiatry’s story of hopelessness and chronic illness that is so often sold to patients.
  • How Olga now views her work from a post-psychiatry perspective.

Relevant links:

Psycovery

Olga’s posts on Mad in America

The Hearing Voices network

International Institute for Psychiatric Drug Withdrawal

Postpsychiatry: a new direction for mental health

To get in touch with us email: [email protected]

Peter Breggin, MD: The Conscience of Psychiatry

0

This week we have a very special guest for you, it has been my honour to be able to interview Dr. Peter Breggin.

Dr. Breggin is a Harvard-trained psychiatrist and former Consultant at the National Institute of Mental Health (NIMH). He has been called “The Conscience of Psychiatry” for his many decades of successful efforts to reform the mental health field.

His work provides the foundation for modern criticism of psychiatric diagnoses and drugs, and leads the way in promoting more caring and effective therapies. His research and educational projects have brought about major changes in the FDA-approved Full Prescribing Information or labels for dozens of antipsychotic and antidepressant drugs. He continues to educate the public and professions about the tragic psychiatric drugging of America’s children.

He has authored dozens of scientific articles and more than twenty books, including medical books and the bestsellers Toxic Psychiatry and Talking Back to Prozac. His most recent three books are Guilt, Shame and Anxiety: Understanding and Overcoming Negative Emotions; Medication Madness: the Role of Psychiatric Drugs in Cases of Violence, Suicide and Murder; and Psychiatric Drug Withdrawal: A Guide for Prescribers, Therapists, Patients and their Families.

As a medical-legal expert, Dr. Breggin has unprecedented and unique knowledge about how the pharmaceutical industry too often commits fraud in researching and marketing psychiatric drugs. He has testified many times in malpractice, product liability and criminal cases, often in relation to adverse drug effects and more occasionally electroshock and psychosurgery. A list of his trial testimony since 1985 is contained in the last section of his Resume on Dr. Breggin’s website.

Dr. Breggin has taught at many universities and has a private practice of psychiatry in Ithaca, New York.

For a career as long and distinguished as Dr. Breggin’s we have decided to devote two episodes to hearing him speak. This first part covers Dr. Breggin’s career, his views on psychiatry and psychiatric drugs and also recent developments with the trial involving Michelle Carter.

Part 2 of the interview will focus more on the trial and Dr. Breggin’s involvement.

In this episode, we discuss:

  • How, age just 18, Dr. Breggin worked as a volunteer in a metropolitan state hospital in 1954.
  • That his immediate impression was a comparison with German concentration camps as he witnessed the brutality including lobotomy and insulin coma therapy.
  • How when the drugs were introduced, primarily Thorazine, the patients would quieten, becoming docile and obedient.
  • That this was brain damage for the purpose of control.
  • That Dr. Breggin then wanted to go to medical school and become part of the reform movement.
  • That, in the 1950s, there were still psychiatrists that had an interest and training in  psychological therapy or psychoanalytic approaches, and social and community psychology.
  • That this also resulted in psychiatry becoming very hostile towards psychosocial approaches, which were less expensive and better.
  • Then, in the 1960s, psychiatry went into partnership with the drug companies and got richer.
  • That Dr. Breggin then entered private practice and learned that lobotomy was making a comeback. This led to a multi year, international campaign to halt the use of lobotomy and psychosurgery in the western world.
  • Since then, Dr. Breggin has also campaigned tirelessly to make changes in the FDA labelling of psychotropic drugs.
  • That Dr. Breggin feels blessed to have been able to stand up for others but also occasionally feels worried by the attacks from the psychiatric establishment.
  • How Dr. Breggin feels that we should tell the truth about psychiatric drugs and that claims of ‘scaremongering’ is a mechanism to reduce criticism of the drugs.
  • That informing people is very different compared to frightening them.
  • That each individual person is still the best judge of when and how to go about withdrawing from psychiatric medications.
  • That Dr. Breggin feels that psychiatry has no economic incentive to change, so the consumer has to stop going to psychiatrists for medications.
  • How the District Attorney in the Michelle Carter case is now trying to stop Dr. Breggin’s Mad in America blogs about her case.

Relevant Links

Peter Breggin’s personal website

Peter’s blogs on Mad in America:

Part 1

Part 2

Michelle Carter Blogs and Archives

The handwritten note from the DA to the Judge about stopping Dr. Breggin’s blog

Toxic Psychiatry

Talking Back to Prozac

Guilt, Shame and Anxiety: Understanding and Overcoming Negative Emotions

Medication Madness: the Role of Psychiatric Drugs in Cases of Violence, Suicide and Murder

Psychiatric Drug Withdrawal: A Guide for Prescribers, Therapists, Patients and their Families.

To get in touch with us via email: [email protected]

Atenção Psicossocial, Atenção Básica e Território, o que estes três termos aportam para as políticas de saúde pública?

0

CAMILAO artigo Atenção Psicossocial e atenção básica: a vida como ela é no território, dos pesquisadores Silvio Yasui, Cristina Amélia Luzio e Paulo Amarante, trata sobre a relação entre três termos muito caros à saúde mental e presentes nas políticas públicas de saúde, a atenção psicossocial, a atenção básica e território. O objetivo é expor alguns dos significados presentes quando se fala desses três termos, além de contribuir para a reflexão sobre os elementos que compõe as práticas de saúde, aproximando essas mesmas práticas à complexidade da vida.

download (1)

Atenção Psicossocial é o primeiro termo trabalhado pelos autores, o qual se trata de uma busca por alternativa à racionalidade psiquiátrica, enquanto redução do funcionamento psíquico ao seu funcionamento neurobioquímico e aos processos cerebrais, nomeando  os desvios a esse funcionamento de transtornos mentais. A Atenção Psicossocial, pelo contrário, procura olhar para o sofrimento humano em seu vínculo com o plano de vida.

O objeto de interesse sofre aqui uma mudança, deixa de ser a doença e passa a ser a complexidade da vida. Não pode mais ser abarcado por apenas uma disciplina ou campo, ele exige uma perspectiva que privilegie um profundo e intenso diálogo entre diferentes e diversas disciplinas e conhecimentos sobre o humano, apagando os limites e fronteiras e permitindo possibilidades diversas para pensar e fazer. Essa perspectiva é denominada por Passos e Barros (2000) como transdisciplinaridade.

O sujeito da experiência da loucura, antes objeto de saber, era isolado para receber o tratamento terapêutico. Hoje, deixou de ser objeto e transformou-se em sujeito, seu cuidado torna-se criação de possibilidades, cujo acontecimento se dá na vida cotidiana, assim como os desafios que devem ser enfrentados.

A psiquiatria e a saúde mental sempre tiveram uma relação íntima com o espaço urbano, sendo exemplo de controle social e poder exercido sobre os sujeitos, ademais de orientar as condutas e comportamentos morais socialmente aceitos. Os espaços urbanos também apresentam divisões, hierarquização, estabelecendo quem pode ou não circular. Dessa forma, o termo território, pode ser um espaço da racionalização dominante, do exercício do controle e da captura. Mas para Deleuze, também é um lugar passível de surgimento de formas e processos de resistência.

Trazendo o território para a perspectiva da Atenção Psicossocial:

“(…) trata-se, então, de acompanhar, cuidar e investir em movimentos de resistência, de produção singular da existência para que estes possam operar a criação de uma nova terra na qual seja possível traçar linhas de vida. ”

Ou seja, significar estar atento, ver, ouvir e incentivar a vida que palpita em cada território.

A Atenção básica compartilha com a atenção psicossocial a forma de olhar o sujeito que adoece. Este olhar não se limita a um corpo que adoece, ele é atravessado por múltiplos planos (histórico social, econômico) e pelas múltiplas histórias que compõe a singularidade de cada situação.

“Produzir saúde é produção de modos de fazer andar a vida (Canguilhem, 1966/2009). ”

Atenção psicossocial e atenção básica também podem compartilhar uma armadilha que se apresenta no cotidiano de ambos os serviços, a lógica manicomial. Esta lógica supera as estruturas físicas do manicômio, podendo estar presentes em outros espaços. Caracteriza-se por ser um poder normatizador que exclui e reprime, não só os loucos, mas todos aqueles que saem dos limites da “boa conduta”, aqui entram os homossexuais, dependentes químicos, moradores de rua, etc.

“Especificamente nos espaços e serviços da saúde mental, este poder se evidencia quando profissionais não conseguem operar um cuidado efetivo, especialmente nas crises, e têm como única solução a intervenção medicamentosa e a internação. Ou, mais sutilmente ainda, quando as intervenções dos profissionais são pautadas por julgamentos morais que prescrevem aos usuários modos corretos de se comportar ou de agir frente as contingências que a vida apresenta. Cabe aqui ressaltar que o uso extensivo e indiscriminado dos medicamentos psicotrópicos é prática naturalizada nos serviços de saúde e, em especial, na Atenção Básica. ”

Por fim, os autores consideram que a reflexão apresentada possibilita traçar algumas linhas de atuação para os profissionais de saúde. Primeiro, é necessário dar atenção às várias formas presentes no modo como cada pessoa vive, considerar e ativar os dispositivos presentes no território, se responsabilizar pelas demandas, de maneira especial, nos momentos de crise, criar diversas e variadas estratégias de cuidado.  Há que estar sempre atento para não cair na rotina do dia a dia e perder de vista a elaboração de um contínuo movimento de construção e desconstrução.

Artigo completo →

 

Peter Breggin, MD: The Conscience of Psychiatry (part 2)

0

This week we present part 2 of our interview with Dr Peter Breggin.

Dr Breggin is a Harvard-trained psychiatrist and former Consultant at the National Institute of Mental Health (NIMH). He has been called “The Conscience of Psychiatry” for his many decades of successful efforts to reform the mental health field.

His work provides the foundation for modern criticism of psychiatric diagnoses and drugs and leads the way in promoting more caring and effective therapies. His research and educational projects have brought about major changes in the FDA-approved Full Prescribing Information or labels for dozens of antipsychotic and antidepressant drugs. He continues to educate the public and professions about the tragic psychiatric drugging of America’s children.

He has authored dozens of scientific articles and more than twenty books, including medical books and the bestsellers Toxic Psychiatry and Talking Back to Prozac. His most recent three books are Guilt, Shame and Anxiety: Understanding and Overcoming Negative Emotions; Medication Madness: the Role of Psychiatric Drugs in Cases of Violence, Suicide and Murder; and Psychiatric Drug Withdrawal: A Guide for Prescribers, Therapists, Patients and their Families.

As a medical-legal expert, Dr Breggin has unprecedented and unique knowledge about how the pharmaceutical industry too often commits fraud in researching and marketing psychiatric drugs. He has testified many times in malpractice, product liability and criminal cases, often in relation to adverse drug effects and more occasionally electroshock and psychosurgery.

Dr Breggin has taught at many universities and has a private practice of psychiatry in Ithaca, New York.

For a career as long and distinguished as Dr Breggin’s we have decided to devote two episodes to hearing him speak. The first part covered Dr Breggin’s career, his views on psychiatry and psychiatric drugs and also recent developments in the trial involving Michelle Carter.

Part 2 of the interview focuses more on recent events surrounding the trial and alternatives to psychiatric drugs.

 

In this episode, we discuss:

  • That Bristol County Juvenile Court Judge Lawrence Moniz sentenced Michelle Carter to a two-and-a-half-year term, with 15 months in jail and the balance suspended plus a period of supervised probation.
  • How Judge Moniz granted a defense motion to stay the sentence, meaning she will remain free pending her appeals in Massachusetts.
  • That if Michelle lost all of her appeals in 2-3 years time, Michelle may be facing custodial time.
  • That attempts to limit Dr Breggin’s right to blog about the trial were stopped and the Judge’s final order in response to DA makes no criticism or censorship of Dr Breggin.
  • That Dr Breggin reviewed thousands of text messages between Michelle and her friends and between Michelle and Conrad Roy, but that one particular part of a text exchange formed the central plank of the case against Michelle.
  • That Dr Breggin is keen to show, through the Michelle Carter blogs, what is happening to our children when they become involved with psychiatry and psychiatric drugs.
  • That Dr Breggin appreciates the suffering of the family of Conrad Roy because he kept hidden how bad his mental health difficulties were.
  • How Dr Breggin also appreciates how Michelle had been tormented and attacked by the press during the trial.
  • How the authorities went to extremes to exclude the role that psychiatric drugs may have played in the events surrounding Michelle and Conrad.
  • How Dr Breggin has observed that many that he has helped that have been wounded by psychiatry, have shied away from becoming reformers themselves.
  • How, when working with clients, Dr Breggin makes sure he takes the time to ensure that potential clients know who he is and how his approach differs to mainstream psychiatry.
  • That Dr Breggin feels that the hostility towards those who question the use of psychiatric drugs has reduced over the last 10 to 20 years.
  • How Dr Breggin feels that the psychiatric drugging of our children is tantamount to organised child abuse because the child cannot make a judgement for themselves.
  • That many children end up taking the drugs to please their parents.
  • That the drug that Michelle Carter was taking (Celexa/Citalopram) was not approved by the FDA for treating children.
  • That Dr Breggin’s view is that emotional or psychological difficulties often are precipitated by childhood trauma.
  • How people often then react to the current world as if it were the world that they found traumatic and difficult as a child.
  • That good therapy has much in common with coaching in sport or certain aspects of religion or good teaching.
  • That all psychoactive substances, including psychiatric drugs, have a general effect on the brain and often this intoxication affects a persons ability to relate emotionally to family and friends.
  • How helping people with their mental health comes down to loving, caring, relationship, coaching and guidance.
  • That these principles have much in common with good religion or philosophy.

Relevant Links

Peter Breggin’s personal website

Peter’s blogs on Mad in America:

Part 1

Part 2

Part 3

Part 4

Part 5

Michelle Carter Blogs and Archives

The handwritten note from the DA to the Judge about stopping Dr Breggin’s blog

Judge’s Final Order in Response to DA Makes No Criticism or Censorship of Dr Breggin

Toxic Psychiatry

Talking Back to Prozac

Guilt, Shame and Anxiety: Understanding and Overcoming Negative Emotions

Medication Madness: the Role of Psychiatric Drugs in Cases of Violence, Suicide and Murder

Psychiatric Drug Withdrawal: A Guide for Prescribers, Therapists, Patients and their Families

To get in touch with us email: [email protected]

Grupos de Defesa dos Paciente Recebem Milhões dos Fabricantes de Drogas Farmacêuticas

0

A Kaiser Health News lançou um novo banco de dados chamado Pre $ scription for Power, que expõe doações de empresas farmacêuticas a grupos de defesa de pacientes. Os dados mostram que a Big Pharma doou pelo menos US $ 116 milhões para grupos de defesa de pacientes em um único ano.

Artigo →

Prescription

Will Hall: A Harm Reduction Approach to Mental Health and Wellbeing

0

This week, we have an interview with Will Hall. Will is a mental health advocate, counsellor, writer, and teacher. Will advocates the recovery approach to mental illness and is recognised internationally as an innovator in the treatment and social response to psychosis.

In 2001, he co-founded the Freedom Center and from 2004-2009 was a co-coordinator for The Icarus Project. He has consulted for Mental Disability Rights International, the Family Outreach and Response Program,  and the Office on Violence Against Women, and in 2012 presented to the American Psychiatric Association‘s Institute on Psychiatric Services.

As an author, Will has written extensively on mental health, social justice, and environmental issues, he is well known for the excellent Harm Reduction Guide to Coming Off Psychiatric Medications which is one of the first places that listeners should look to for help and support when considering taking or withdrawing from psychiatric medications. Will’s latest book is Outside Mental Health: Voices and Visions of Madness, released in 2016 it presents interviews with more than 60 psychiatric patients, scientists, journalists, doctors, activists, and artists to create a vital new conversation about empowering the human spirit. Outside Mental Health invites us to rethink what we know about bipolar, psychosis, schizophrenia, depression, medications, and mental illness in society.

Will also hosts Madness Radio which broadcasts on FM and is also available as a podcast. For listeners, I recommend that you listen in and subscribe to the Madness radio podcast, particularly as the Harm reduction guide to coming off psychiatric medications can be heard in full here.

In this episode, we discuss:

  • How Will became involved with the psychiatric system while living in the San Francisco Bay area
  • His experiences of being treated with a wide range of psychiatric drugs
  • How he came to meet with other psychiatric survivors and take control of his own recovery
  • The setting up of the Freedom Centre in Western Massachusetts
  • The creation of the ‘Harm reduction guide to coming off psychiatric drugs’
  • How this led to Will’s work in counselling, training and education around psychiatric drugs
  • How Will approached collaborating with a wide range of contributors to develop the Harm reduction guide
  • That Will wanted to adopt a careful, non judgemental approach to his work to support people with their medications
  • How Will feels he reached more people because they knew that they weren’t going to be judged
  • That the research and evidence does not support the idea that psychiatric drugs are treating some brain disease or correcting an underlying brain chemical imbalance
  • The fear that exists around these kind of mental health difficulties
  • The dangers of psychiatric drugs
  • That people with lived experience of psychiatric medications need to share their experiences, particularly where withdrawal is concerned
  • That sometimes passivity can contribute to reliance on medications but people need to take their health into their own hands
  • That we should really be looking to a community based approach to supporting people with emotional distress or trauma
  • That we need to create healthy communities that support each other
  • That if people are considering stopping their psychiatric drugs they should make use of the Harm reduction guide because there is no single answer
  • That people should also make sure that they have a support network in place because stopping the drugs can become an isolating experience
  • That drug withdrawal is a life change process not just a chemical change in your brain
  • That psychiatry can make no claim to have answered the mind/body question
  • That fear is a big factor when considering not relying on medication
  • That where withdrawal is concerned, time tends to be on your side if you can get through the discomfort and difficulty

Relevant Links:

Will’s personal website

Madness Radio

The Icarus Project

Outside Mental Health: Voices and Visions of Madness


How to Listen:

To listen in iTunes, click here

To listen on YouTube, click here

To get in touch with us email: [email protected]

Noticias

Blogues